44.11000 EUR
0.06
0.14%
Last update Dec 18, 7:31 PM CET
Market closed
Day range
44.060001
44.30000
Previous close
44.17000
Open
44.060001
Access this stock data via API
Subscribe
Biomarin Pharmaceutical Inc.
44.11
0.06
0.14%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 661.6M 703.7M 635.2M 637.1M
Cost of revenue 119.4M 128.0M 129.2M 116.1M
Gross profit 542.2M 575.7M 506.0M 521.0M
Operating expense
Research & development 349.1M 137.5M 135.3M 147.9M
Selling general and admin 228.8M 198.0M 175.7M 227.3M
Other operating expenses
Operating income -39.8M 236.0M 190.9M 137.6M
Non operating interest income
Income 15.2M 16.0M 16.2M 15.1M
Expense 2.2M 2.3M 2.4M 1.9M
Other income expense 4.3M 4.1M -1.7M -5.9M
Pretax income -22.4M 253.9M 203.0M 144.6M
Tax provision 3.8M 48.9M 44.7M 38.1M
Net income -26.2M 205.1M 158.3M 106.5M
Basic EPS 1.3 1.0 0.7
Diluted EPS 1.2 1.0 0.6
Basic average shares 163.6M 162.8M 162.6M
Diluted average shares 168.0M 167.5M 167.6M
EBITDA -4.5M 272.0M 224.2M 166.7M
Net income from continuing op. -26.2M 205.1M 158.3M 106.5M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 11 hours 5 minutes

20:54
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).